Promega to Showcase Applications of Bioluminescent Research Tools at Global Seminar Series
Promega will demonstrate applications of bioluminescence tools at Discover Glo 2021.
Promega Corporation announced that it will showcase various applications of bioluminescence research tools at their Discover Glo 2021 conference, a virtual event which will be held Sept. 13–16, 2021.
The aim of the conference is to advance understanding in key therapeutic areas, such as targeted protein degradation and kinase biology. Each day will feature discussions focusing on a topic surrounding luciferase technologies.
These daily topics include:
- Bioluminescence: Past, Present, Future (Sept. 13)
- Applications of CRISPR Knock-in Tagging for Studying Endogenous Protein Dynamics (Sept. 14)
- Understanding Kinase Target Engagement in Live Cells (Sept. 15)
- Advances in Targeted Protein Degradation (Sept. 16)
Prominent speakers from various related fields will be in attendance. For a full list of these individuals, the company press release can be found here.
Source: Promega
New Cancer Research and Treatment Center in Development in London
May 1st 2025Aviva Capital Partners and developer Socius are investing £1 billion in a 12-acre site to be located at the London Cancer Hub next to The Institute of Cancer Research, London and The Royal Marsden NHS Foundation Trust’s Sutton site.
